240 related articles for article (PubMed ID: 24330594)
1. Increasing teacher motivation and supervision is an important but not sufficient strategy for improving praziquantel uptake in Schistosoma mansoni control programs: serial cross sectional surveys in Uganda.
Muhumuza S; Katahoire A; Nuwaha F; Olsen A
BMC Infect Dis; 2013 Dec; 13():590. PubMed ID: 24330594
[TBL] [Abstract][Full Text] [Related]
2. Sustaining Control of Schistosomiasis Mansoni in Western Côte d'Ivoire: Results from a SCORE Study, One Year after Initial Praziquantel Administration.
Assaré RK; Tian-Bi YN; Yao PK; N'Guessan NA; Ouattara M; Yapi A; Coulibaly JT; Meïté A; Hürlimann E; Knopp S; Utzinger J; N'Goran EK
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004329. PubMed ID: 26789749
[TBL] [Abstract][Full Text] [Related]
3. Uptake of preventive treatment for intestinal schistosomiasis among school children in Jinja district, Uganda: a cross sectional study.
Muhumuza S; Olsen A; Katahoire A; Nuwaha F
PLoS One; 2013; 8(5):e63438. PubMed ID: 23667617
[TBL] [Abstract][Full Text] [Related]
4. High level of Schistosoma mansoni infection in pre-school children in Sierra Leone highlights the need in targeting this age group for praziquantel treatment.
Hodges MH; Paye J; Koroma MM; Nyorkor ED; Fofonah I; Zhang Y
Acta Trop; 2012 Nov; 124(2):120-5. PubMed ID: 22820025
[TBL] [Abstract][Full Text] [Related]
5. Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study.
Abudho BO; Ndombi EM; Guya B; Carter JM; Riner DK; Kittur N; Karanja DMS; Secor WE; Colley DG
Am J Trop Med Hyg; 2018 May; 98(5):1397-1402. PubMed ID: 29532768
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of one versus two doses of praziquantel on cure rate of Schistosoma mansoni infection and re-infection in Mayuge District, Uganda.
Tukahebwa EM; Vennervald BJ; Nuwaha F; Kabatereine NB; Magnussen P
Trans R Soc Trop Med Hyg; 2013 Jun; 107(6):397-404. PubMed ID: 23596262
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Schistosoma mansoni infection and the therapeutic efficacy of praziquantel among school children in Manna District, Jimma Zone, southwest Ethiopia.
Bajiro M; Dana D; Ayana M; Emana D; Mekonnen Z; Zawdie B; Garbi A; Kure A; Zeynudin A
Parasit Vectors; 2016 Oct; 9(1):560. PubMed ID: 27772528
[TBL] [Abstract][Full Text] [Related]
8. Reduced uptake of mass treatment for schistosomiasis control in absence of food: beyond a randomized trial.
Muhumuza S; Olsen A; Katahoire A; Nuwaha F
BMC Infect Dis; 2015 Oct; 15():423. PubMed ID: 26466681
[TBL] [Abstract][Full Text] [Related]
9. Cluster randomized trial comparing school-based mass drug administration schedules in areas of western Kenya with moderate initial prevalence of Schistosoma mansoni infections.
Karanja DMS; Awino EK; Wiegand RE; Okoth E; Abudho BO; Mwinzi PNM; Montgomery SP; Secor WE
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006033. PubMed ID: 29059190
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of school-based preventive chemotherapy strategies for sustaining the control of schistosomiasis in Côte d'Ivoire: Results of a 5-year cluster randomized trial.
Ouattara M; Diakité NR; Yao PK; Saric J; Coulibaly JT; Assaré RK; Bassa FK; Koné N; Guindo-Coulibaly N; Hattendorf J; Utzinger J; N'Goran EK
PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008845. PubMed ID: 33449924
[TBL] [Abstract][Full Text] [Related]
11. Mass drug administration significantly reduces infection of Schistosoma mansoni and hookworm in school children in the national control program in Sierra Leone.
Hodges MH; Dada N; Warmsley A; Paye J; Bangura MM; Nyorkor E; Sonnie M; Zhang Y
BMC Infect Dis; 2012 Jan; 12():16. PubMed ID: 22264258
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
[TBL] [Abstract][Full Text] [Related]
13. Understanding low uptake of mass treatment for intestinal schistosomiasis among school children: a qualitative study in Jinja district, Uganda.
Muhumuza S; Olsen A; Nuwaha F; Katahoire A
J Biosoc Sci; 2015 Jul; 47(4):505-20. PubMed ID: 24735860
[TBL] [Abstract][Full Text] [Related]
14. Observed reductions in Schistosoma mansoni transmission from large-scale administration of praziquantel in Uganda: a mathematical modelling study.
French MD; Churcher TS; Gambhir M; Fenwick A; Webster JP; Kabatereine NB; Basáñez MG
PLoS Negl Trop Dis; 2010 Nov; 4(11):e897. PubMed ID: 21124888
[TBL] [Abstract][Full Text] [Related]
15. Re-assessment of schistosomiasis in nine endemic districts with cluster sampling in Sierra Leone.
Kargbo-Labour I; Redwood-Sawyerr V; Conteh A; Chop E; Bah MS; Koroma A; Kabia U; Klein L; Juneja S; Houck P; Reid S; Evans D; Weaver AM; Phillips AE; Zhang Y
Front Public Health; 2024; 12():1415486. PubMed ID: 38932788
[TBL] [Abstract][Full Text] [Related]
16. Five-Year Follow-Up on the Prevalence and Intensity of Infections of Schistosoma mansoni in a Hard-to-Reach District of Madagascar.
Spencer SA; Linder C; Penney JMS; Russell HJ; Hyde K; Sheehy C; Reid A; Andriamasy EH; Raderalazasoa GU; Rakotomampianina DAL; Nandimbiniaina AM; Ranaivoson TN; Andrianiaina A; Cruickshank SM; Bustinduy AL; Stothard JR; Edosoa GT; Rahetilahy AM;
Am J Trop Med Hyg; 2021 Mar; 104(5):1841-1850. PubMed ID: 33684064
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of morbidity in Schistosoma mansoni-positive primary and secondary school children after four years of mass drug administration of praziquantel in western Kenya.
Abudho BO; Guyah B; Ondigo BN; Ndombi EM; Ireri E; Carter JM; Riner DK; Kittur N; Karanja DMS; Colley DG
Infect Dis Poverty; 2020 Jun; 9(1):67. PubMed ID: 32539826
[TBL] [Abstract][Full Text] [Related]
18. Intestinal schistosomiasis of Ijinga Island, north-western Tanzania: prevalence, intensity of infection, hepatosplenic morbidities and their associated factors.
Mueller A; Fuss A; Ziegler U; Kaatano GM; Mazigo HD
BMC Infect Dis; 2019 Oct; 19(1):832. PubMed ID: 31590657
[TBL] [Abstract][Full Text] [Related]
19. Identification of transmission foci of Schistosoma mansoni: narrowing the intervention target from district to transmission focus in Ethiopia.
Tiruneh A; Kahase D; Zemene E; Tekalign E; Solomon A; Mekonnen Z
BMC Public Health; 2020 May; 20(1):769. PubMed ID: 32448159
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
